Home6185 • HKG
add
Cansino Biologics Inc
Previous close
$39.68
Day range
$39.54 - $40.28
Year range
$25.25 - $56.55
Market cap
13.92B HKD
Avg Volume
865.56K
P/E ratio
-
Dividend yield
-
Primary exchange
HKG
Market news
Financials
Income Statement
Revenue
Net income
| (CNY) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 310.24M | 17.67% |
Operating expense | 218.49M | 5.76% |
Net income | 27.93M | 842.01% |
Net profit margin | 9.00 | 703.57% |
Earnings per share | — | — |
EBITDA | 82.74M | 8.06% |
Effective tax rate | -0.48% | — |
Balance Sheet
Total assets
Total liabilities
| (CNY) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.79B | -14.99% |
Total assets | 7.30B | -8.62% |
Total liabilities | 2.37B | -19.01% |
Total equity | 4.93B | — |
Shares outstanding | 182.59M | — |
Price to book | 1.47 | — |
Return on assets | 1.21% | — |
Return on capital | 1.38% | — |
Cash Flow
Net change in cash
| (CNY) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | 27.93M | 842.01% |
Cash from operations | 22.22M | 130.36% |
Cash from investing | -45.87M | 92.90% |
Cash from financing | -474.91M | -297.10% |
Net change in cash | -498.03M | 41.57% |
Free cash flow | -147.95M | 52.66% |
About
CanSino Biologics, often abbreviated as CanSinoBIO, is a Chinese vaccine company. Wikipedia
CEO
Founded
Jan 13, 2009
Website
Employees
1,115
